LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

Accueil・Liste d'Actions・Ventyx Biosciences Inc

Ventyx Biosciences Inc

Fermé

13.99

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

13.99

Max

13.99

Chiffres clés
By Trading Economics
Revenu	4.2M -23M
Employés	83
EBITDA	6.6M -23M

Recommandations
By TipRanks
Recommandations	Neutre
Prévisions sur 12 Mois	-4.43% downside

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	418M 1B
Ouverture précédente	13.99
Clôture précédente	13.99

Ventyx Biosciences Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 mars 2026, 23:12 UTC

Actions en Tendance

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12 mars 2026, 22:15 UTC

Résultats

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12 mars 2026, 21:42 UTC

Principaux Événements d'Actualité

Stryker Says Cyberattack Disruption Is Continuing

12 mars 2026, 21:29 UTC

Principaux Événements d'Actualité

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12 mars 2026, 21:27 UTC

Résultats

Adobe CEO to Depart as AI Boosts Sales -- Update

12 mars 2026, 20:46 UTC

Résultats

Adobe Posts Higher Sales With CEO Set to Depart

12 mars 2026, 20:21 UTC

Principaux Événements d'Actualité

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12 mars 2026, 23:57 UTC

Market Talk

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12 mars 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 mars 2026, 23:38 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12 mars 2026, 22:13 UTC

Résultats

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12 mars 2026, 22:13 UTC

Résultats

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12 mars 2026, 22:13 UTC

Résultats

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12 mars 2026, 22:13 UTC

Résultats

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12 mars 2026, 22:13 UTC

Résultats

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12 mars 2026, 22:13 UTC

Market Talk

Résultats

Global Equities Roundup: Market Talk

12 mars 2026, 22:13 UTC

Market Talk

Résultats

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12 mars 2026, 21:16 UTC

Acquisitions, Fusions, Rachats

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12 mars 2026, 21:04 UTC

Résultats

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12 mars 2026, 21:02 UTC

Résultats

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12 mars 2026, 21:02 UTC

Résultats

Wheaton Precious Metals 4Q Sales $865M >WPM

12 mars 2026, 21:02 UTC

Résultats

Wheaton Precious Metals 4Q Net $558.3M >WPM

12 mars 2026, 21:02 UTC

Résultats

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12 mars 2026, 20:57 UTC

Market Talk

Principaux Événements d'Actualité

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12 mars 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 mars 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 mars 2026, 20:15 UTC

Acquisitions, Fusions, Rachats

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12 mars 2026, 20:10 UTC

Résultats

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12 mars 2026, 20:05 UTC

Résultats

Adobe 1Q Rev $6.4B >ADBE

12 mars 2026, 20:05 UTC

Résultats

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Comparaison

Variation de prix

Ventyx Biosciences Inc prévision

Objectif de Prix

By TipRanks

-4.43% baisse

Prévisions sur 12 Mois

Moyen 13.38 USD -4.43%

Haut 14 USD

Bas 9 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

Achat

Maintien

Vente

Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

À Propos Ventyx Biosciences Inc

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.